Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Therapeutics and Clinical Risk Management|October 6, 2016
In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patientsAbdel Naser Zaid, Masshour Ghanem, Dua'a Shweiki, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|June 13, 2022
Following drug degradation and consequent taste deterioration of an oral reconstituted paediatric suspension during dosing interval via electronic tongueAbdel Naser Zaid, Rowa Al Ramahi, Alaaldin AlKilany, et al.BMC Complementary and Alternative Medicine|May 10, 2017
Ethnopharmacological survey of medicinal plants practiced by traditional healers and herbalists for treatment of some urological diseases in the West Bank/PalestineNidal Amin Jaradat, Abdel Naser Zaid, Rowa Al-Ramahi, et al.Journal of Cosmetic Science|March 29, 2022
Formulation and In Vitro and In Vivo Assessment of Natural Emulgel Containing Lemongrass Essential OilAbdel Naser Zaid, Nidal Jaradat, Ramzi Shawahna, et al.Bioorganic & Medicinal Chemistry|December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.Journal of Medicinal Chemistry|December 14, 2011
Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonistsPier Giovanni Baraldi, Stefania Baraldi, Giulia Saponaro, et al.Journal of Medicinal Chemistry|June 17, 2011
New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Abdel Naser Zaid, et al.Pageof 7